Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
ipo
2
×
life sciences
national blog main
national top stories
new york blog main
new york top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
startups
2
×
vc
accent therapeutics
acetylon pharmaceuticals
aducanumab
alzheimer's disease
amblyotech
ambys medicines
asklepios biopharmaceutical
bioeurope
biogen
biomarin pharmaceutical
boulder/denver blog main
boulder/denver top stories
brainvectis
c. greg guyer
cancer
cara therapeutics
cell therapy
constellation pharmaceuticals
deals
deerfield management
detroit blog main
detroit top stories
drug development
drug discovery
esperion
What
medicines
2
×
new
2
×
activity
aiming
ambys
approvals
big
bio
biogen
biotech
clamped
control
covid
deadly
deal
debuted
delays
developing
diseases
economic
fast
fda
formed
future
including
ipo
isn’t
launch
liver
lot
make
oric’s
roundup
showing
spread
startup
takeda
testing
today
treatments
Language
unset
Current search:
medicines
×
ipo
×
startups
×
new
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?